Consonance Investment Managers
Impact investorLagos · Pre-Seed–Late Stage
Frequently asked questions
- What stage does Consonance Investment Managers invest at?
- Consonance Investment Managers invests at the Pre-Seed, Seed, Series A, Late Stage stages.
- What sectors does Consonance Investment Managers focus on?
- Consonance Investment Managers focuses on Impact & Social Good.
- Where is Consonance Investment Managers located?
- Consonance Investment Managers is headquartered in Lagos, NG.
Similar investors
500 Global's Sustainable Growth practice designs and implements sovereign-aligned strategies that unlock resilient, inclusive, and sustainable economic growth across the Global Majority—Asia, Africa, Latin America, and the Middle East. The practice bridges public priorities and private capital through ecosystem development, blended finance, and localized innovation programs addressing health, agriculture, gender, climate, and education.
B Capital is a venture capital firm managing $12+ billion in assets under management with 200+ early to late-stage portfolio companies across 9 global locations. The firm operates dedicated stage-based funds supporting entrepreneurs throughout the company-building lifecycle.
Blue Horizon is an investment firm focused on advancing sustainable food systems through mission-aligned founders operating at the intersection of biology, technology, and agriculture. The firm supports the growth and consolidation of leading platforms in this space.
Elevar Equity is an impact-focused investment firm that applies the Elevar Method to identify and scale commercial businesses serving underserved populations in emerging markets. The firm works with companies in agriculture, education, and digital transformation across Latin America, India, and other regions.
Lundbeckfonden is a foundation that invests actively in business and science, with a focus on bringing discoveries to lives through creating ripple effects. The organization is committed to doubling fixed research distributions in Denmark by 2030, developing a more strategic focus on the brain, expanding long-term healthcare ownership, and strengthening collaboration between research and business.